Skip to main content
. 2021 Mar 3;18(5):2497. doi: 10.3390/ijerph18052497

Figure 2.

Figure 2

Phase-2 extended Susceptible-Vaccinated-Exposed-Infected-Recovered (SVEIR) model with a vaccination rate φt at day t.